The Utility of Health States After Stroke: A Systematic Review of the Literature
暂无分享,去创建一个
Peter P. Wakker | Anne M. Stiggelbout | A. Stiggelbout | P. Wakker | P. Post | Piet N. Post | P. N. Post
[1] H. Schouten,et al. Interobserver agreement for the assessment of handicap in stroke patients. , 1988, Stroke.
[2] P. Glasziou,et al. Quality of life six months after myocardial infarction treated with thrombolytic therapy , 1994, The Medical journal of Australia.
[3] G. Naglie,et al. Quality of life of stroke in younger individuals. Utility assessment in patients with arteriovenous malformations. , 1997, Stroke.
[4] G W Torrance,et al. Multi-attribute health status classification systems. Health Utilities Index. , 1995, PharmacoEconomics.
[5] J. Lee,et al. Patient Preferences for Stroke Outcomes , 1994, Stroke.
[6] Tammy O. Tengs,et al. One thousand health-related quality-of-life estimates. , 2000, Medical care.
[7] D K Owens,et al. The effect of stroke and stroke prophylaxis with aspirin or warfarin on quality of life. , 1996, Archives of internal medicine.
[8] P. Duncan,et al. Utilities for major stroke: results from a survey of preferences among persons at increased risk for stroke. , 1998, American heart journal.
[9] D. Fryback,et al. Toward consistency in cost-utility analyses: using national measures to create condition-specific values. , 1998, Medical care.
[10] R. Califf,et al. Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries. , 1995, Circulation.
[11] R. Thomson,et al. Decision analysis and guidelines for anticoagulant therapy to prevent stroke in patients with atrial fibrillation , 2000, The Lancet.
[12] M. Weinstein,et al. The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. , 1996, JAMA.
[13] D. Matchar,et al. Depression and Other Determinants of Values Placed on Current Health State by Stroke Patients: Evidence From the VA Acute Stroke (VASt) Study , 2000, Stroke.
[14] R. Bloch,et al. Interobserver agreement for the assessment of handicap in stroke patients. , 1988, Stroke.
[15] M. Gold. Cost-effectiveness in health and medicine , 2016 .
[16] A. House,et al. Mood Disorders in the Year after First Stroke , 1991, British Journal of Psychiatry.
[17] H. Sutherland. Assessing patients' preferences. , 1995, Medical decision making : an international journal of the Society for Medical Decision Making.
[18] J. Bamford,et al. Classification and natural history of clinically identifiable subtypes of cerebral infarction , 1991, The Lancet.
[19] A. Laupacis,et al. Patient Preference-based Treatment Thresholds and Recommendations , 2000, Medical decision making : an international journal of the Society for Medical Decision Making.
[20] P Sandercock,et al. Are the modified “simple questions” a valid and reliable measure of health related quality of life after stroke? , 2000, Journal of neurology, neurosurgery, and psychiatry.
[21] A M Stiggelbout,et al. Patient preference for cancer therapy: an overview of measurement approaches. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[22] D K Owens,et al. Cost-effectiveness of warfarin and aspirin for prophylaxis of stroke in patients with nonvalvular atrial fibrillation. , 1995, JAMA.
[23] E. Cohen,et al. Carotid Endarterectomy for Symptom-free Stenosis: The Patient's Point of View , 1994, Cardiovascular surgery.
[24] P. Duncan,et al. Defining post-stroke recovery: implications for design and interpretation of drug trials , 2000, Neuropharmacology.
[25] R. Klein,et al. The Beaver Dam Health Outcomes study , 1993, Medical decision making : an international journal of the Society for Medical Decision Making.
[26] Milton C. Weinstein,et al. The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. , 1996 .
[27] P. Dorman,et al. Is the EuroQol a valid measure of health-related quality of life after stroke? , 1997, Stroke.
[28] D. Feeny,et al. Health Utilities Index Mark 3: evidence of construct validity for stroke and arthritis in a population health survey. , 2000, Medical care.
[29] S. Slørdahl,et al. Stroke unit treatment improves long-term quality of life: a randomized controlled trial. , 1998, Stroke.
[30] C. Anderson,et al. Predicting Survival for 1 Year Among Different Subtypes of Stroke Results From the Perth Community Stroke Study , 1994, Stroke.
[31] S. Hallan,et al. Quality of life after cerebrovascular stroke: a systematic study of patients’ preferences for different functional outcomes , 1999, Journal of internal medicine.
[32] P. Dolan,et al. Modeling valuations for EuroQol health states. , 1997, Medical care.
[33] D. Feeny,et al. Use of the Health Utilities Index with stroke patients and their caregivers. , 1997, Stroke.
[34] M C Weinstein,et al. The role of cost-effectiveness analysis in health and medicine. Panel on Cost-Effectiveness in Health and Medicine. , 1996, JAMA.
[35] G W Torrance,et al. Utility approach to measuring health-related quality of life. , 1987, Journal of chronic diseases.
[36] D. Feeny,et al. Multiattribute utility function for a comprehensive health status classification system. Health Utilities Index Mark 2. , 1996, Medical care.
[37] A. Stiggelbout,et al. Explaining Distortions in Utility Elicitation through the Rank-dependent Model for Risky Choices , 1995, Medical decision making : an international journal of the Society for Medical Decision Making.
[38] J. O'Meara,et al. A decision analysis of streptokinase plus heparin as compared with heparin alone for deep-vein thrombosis. , 1994, The New England journal of medicine.